Security readout for executives and security teams
Plain-English summary
This vulnerability means Philips Clinical Collaboration Platform may not reliably verify that a claimed identity is legitimate. In a healthcare environment, that could let an adjacent-network attacker affect limited confidentiality, integrity, or availability. The public record rates it medium, not critical, but clinical workflow impact makes ownership and vendor follow-up important.
Executive priority
Treat this as a moderate medical technology risk. It does not currently have confirmed active exploitation in the provided evidence, but affected clinical collaboration systems should be identified and handled through vendor-supported remediation planning.
Technical view
CVE-2020-16198 is a CWE-693 protection mechanism failure in Philips Clinical Collaboration Platform versions 12.2.1 and prior. The CVSS 3.1 score is 5.0 with adjacent-network access, high attack complexity, no privileges, and no user interaction. Reported impact is low across confidentiality, integrity, and availability.
Likely exposure
Exposure is most likely in healthcare environments still running Philips Clinical Collaboration Platform 12.2.1 or earlier. The CVSS vector indicates the attacker must have adjacent network access, which limits broad internet exposure but still matters inside clinical networks.
Exploitation context
The provided sources do not show CISA KEV listing or active exploitation. The vulnerability is not described as remotely internet-exploitable; the CVSS vector requires adjacent network access and high attack complexity. Evidence is insufficient to claim public exploitation.
Researcher notes
The record describes insufficient proof of claimed identity, mapped to CWE-693. Public details are limited, and the affected-product metadata is sparse. Avoid assuming affected subcomponents, exploit paths, or fixes beyond Philips Clinical Collaboration Platform versions 12.2.1 and prior.
Mitigation direction
- Inventory Philips Clinical Collaboration Platform deployments and confirm exact versions.
- Check Philips and CISA advisories for vendor-approved remediation guidance.
- Prioritize remediation for systems connected to clinical workflow networks.
- Limit platform access to trusted, managed network segments where feasible.
- Monitor for unusual identity, session, or access-control behavior.
Validation and detection
- Confirm whether any deployment runs version 12.2.1 or earlier.
- Review network placement against the adjacent-network attack requirement.
- Check change records for Philips remediation or vendor guidance application.
- Verify monitoring covers authentication and access-control anomalies.
- Document compensating controls if vendor remediation is unavailable.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-693: Exact CWE lookup
Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2020-16198 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Medium
- CVSS
- 5 (3.1)
- Known Exploited
- No
- Published
Vector: CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:L
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS vector scores
1 official scoreWe collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.
CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:L1.63.4Primary CVE scoreVulnerability scoring details
Base CVSS 3.1 score
5MediumVector: CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:L
Source materials
- CVE List V5 sourceCVE List V5
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01CVE reference · x_refsource_MISC
- https://www.philips.com/a-w/security/security-advisories/product-security-2020.html#2020_archiveCVE reference
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.